BiomX (PHGE) Interest Coverage Ratio (2018 - 2026)
BiomX (PHGE) posted Interest Coverage Ratio of 6.75 for Q1 2026, up 99.81% sequentially from 3548.2 in Q4 2025, and up 99.04% YoY from 3.39 in Q1 2025.
BiomX (PHGE) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
BiomX has reported Interest Coverage Ratio for 8 years, with the latest figure at 6.75 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.04% year-over-year to 6.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 40.61 (up 99.02% YoY) and the FY2025 annual result came in at 22.86, up 21.29% from the prior year.
- Interest Coverage Ratio advanced to 6.75 in Q1 2026 per PHGE's latest filing, from 3548.2 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 6.75 in Q1 2026 and troughed at 3548.2 in Q4 2025.
- A 5-year average of 422.28 and a median of 16.05 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 4732.19% in 2025, then surged 99.04% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 111.2 in 2022, then soared by 90.88% to 10.14 in 2023, then plunged by 1614.28% to 173.8 in 2024, then slumped by 1941.52% to 3548.2 in 2025, then jumped by 99.81% to 6.75 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 6.75, 3548.2, and 776.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | -6.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.75 |
| Dec 31, 2025 | -3,548.20 |
| Sep 30, 2025 | -776.00 |
| Jun 30, 2025 | -825.89 |
| Mar 31, 2025 | -705.09 |
| Dec 31, 2024 | -173.80 |
| Sep 30, 2024 | -514.91 |
| Jun 30, 2024 | -17.09 |
| Dec 31, 2023 | -10.14 |
| Sep 30, 2023 | -13.58 |
| Jun 30, 2023 | -8.15 |
| Mar 31, 2023 | -10.99 |
| Dec 31, 2022 | -111.20 |
| Sep 30, 2022 | -11.80 |
| Jun 30, 2022 | -15.01 |
| Mar 31, 2022 | -7.92 |
| Dec 31, 2021 | -11.72 |
| Sep 30, 2021 | -2.21 |
| Dec 31, 2020 | -125.94 |
| Jun 30, 2020 | -1,065.67 |